This study was designed to evaluate the role of Escherichia coli type 1 pili in adherence of the organism to porcine small intestines and the efficacy of pili as a vaccine antigen in controlling neonatal colibacillosis. Our results demonstrated that an E. coli phase cloned to express type 1 pili readily attached to the small intestines of colostrum-deprived newborn pigs. Immunofluorescent staining of intestine sections revealed the presence of E. coli expressing type 1 pili only on the brush border, suggesting involvement of type 1 pili in the colonization process. Administration of anti-type 1 serum to newborn pigs prior to challenge reduced the level of gut-associated E. coli sixfold compared with controls. Purified type 1 pilus vaccine induced significant protection against colibacillosis in newborn pigs following challenge with E. coli expressing type 1 pili. Pigs born to vaccinated gilts scoured less and gained more weight than pigs born to control gilts. Our results demonstrate that type 1 pili are a virulence factor, as well as an effective vaccine antigen.
Neonatal diarrhea is an important disease which affects swine worldwide. There are several etiological agents known to cause diarrhea; the major cause is enterotoxigenic Escherichia coli. Following ingestion, E. coli cells colonize and proliferate in the small intestine and release one or both types of enterotoxins (heat labile or heat stable or both), resulting in diarrhea. Colonization of the intestinal epithelium is mediated by specific surface adhesive antigens known as pili. Four pilus types (types K88, K99, 987P, and F41) have been implicated in the colonization process. Each of these pilus types has been purified and characterized (5, 17, 20, 22) .
Pathogenic and nonpathogenic E. coli isolates have been reported to produce type 1 pili (14) . It has been shown that 42% of the E. coli strains isolated from human diarrhea patients have type 1 pili and produce enterotoxins (13) . E. coli strains expressing type 1 pili have also been isolated from patients with urinary tract infections (11, 15) . E. coli isolates possessing type 1 pili have been shown to adhere to isolated buccal epithelial cells from humans (19) , bovine mammary glands (7) , and porcine intestinal epithelium (9) . Colonization of E. coli expressing type 1 pili to oropharyngeal cells has been demonstrated in rats (6) . In vitro studies have demonstrated that attachment to porcine intestinal epithelium (9) and attachment to human buccal epithelium cells (1, 6, 25) are effectively blocked by type 1 antiserum. Furthermore, type 1 antiserum has been shown to protect mice against pyelonephritis (21) . Brinton et al. (4) showed that 81% of the E. coli strains which they isolated from neonatal pig diarrhea expressed type 1 pili in addition to other known pili. Efforts to protect piglets against colibacillosis by immunization of pregnant dams with a variety of immunogens have been made. The best results were achieved with preparations containing purified pili, such as type K99 or 987P pili (8, 17, 18 (16) .
Immunodiffusion. An Ouchterlony type of immunodiffusion assay was performed in 0.9% agarose (FMC Corp., Rockland, Maine) poured onto a glass microscope slide. Wells were cut in the agar and filled with sample, and the preparations were incubated at room temperature for 24 to 48 h in a humid chamber. The antisera used are described above; the purified E. coli type 1 pili used are also described above.
Determination of gut-associated E. coli. Ileal segments 8 cm long were removed from each pig. Each segment was cut open, washed four times with phosphate-buffered saline (0.14 M NaCl, 2.7 mM KCI, 7 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2) at 4°C, and homogenized in an Omni-mixer (Du Pont); 10-fold serial dilutions of the resulting suspension were made in phosphate-buffered saline and cultured at 37°C for 18 to 24 h on MacConkey agar (Difco) to determine the total bacterial count.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed in a 10% gel by a modification of the procedure of Laemmli (12) . The following samples were examined: sodium dodecyl sulfate-polyacrylamide gel electrophoresis low-molecular-weight standards (Bio-Rad Laboratories, Richmond, Calif.) and E. coli type 1 pili. The pilus preparation was adjusted to a pH value of less than 2 by adding 5 N HCI and heated to 100°C for 5 min. It was cooled to 25C, and the pH was adjusted to 7 by adding 5 N NaOH. The samples were run reduced (3.8% 2-mercaptoethanol) and unheated. The gel (thickness, 1.5 mm) was stained with 0.2% Coomassie brilliant blue R-250 overnight and was destained in a solution containing 40% methanol and 7% acetic acid.
Determination of lipopolysaccharide. The presence of lipopolysaccharide in the purified pilus preparation was determined by using the Limulus amoebocyte lysate test (Associates of Cape Code, Inc., Woods Hole, Mass.) (23) .
Immunofluorescent staining. Porcine ileal segments were prepared as frozen sections to determine the involvement of type 1 pili in the colonization process. This was accomplished by indirect immunofluorescent staining as described by Bertschinger et al. (2) . Frozen sections (thickness, 5 ,um) were made and mounted on microscope slides. Several sections were fixed with 100% acetone and treated with rabbit antisera to type 1, K99, K88, and 987P pili. After three washes with phosphate-buffered saline, the sections were treated with fluoroscein isothiocyanate-conjugated goat anti-rabbit immunoglobulin G (Miles Laboratories, Inc., Elkhart, Ind.). The slides were washed three times with phosphate-buffered saline and observed with a fluorescent microscope (Zeiss, Carl, West Germany).
Vaccine. Each dose of vaccine contained 5 mg of purified type 1 pili in aluminum hydroxide adjuvant.
Attachment assay. The 19 colostrum-deprived newborn pigs were divided into three groups. Each animal in the first group, which consisted of seven pigs, received 10 ml of normal rabbit serum orally. Each animal in the second group, which consisted of eight pigs, received 10 ml of rabbit anti-type 1 serum orally. The animals in the third group, which consisted of four pigs, were held as unchallenged controls. After 45 min each pig was challenged with 2 x 109 E. coli A/001 cells intragastrically. The pigs were isolated individually following challenge. At 9 h postchallenge, the pigs were sacrificed, and ileal segments were removed asceptically for determination of gut-associated bacteria and for immunofluorescent staining.
Vaccine trial. To determine the serological response to the vaccine, 20 mice were immunized subcutaneously with 0.1 ml of the vaccine. The mice were bled 21 days later, and the sera were evaluated by using the agglutination test (26) . Cultures expressing type K88, K99, 987P, or 1 pili only were used as the antigens; this was achieved by growing the cultures on minimal glucose agar plates. The colonies which expressed particular pilus types were determined by their agglutination reactions with pilus-specific antisera. They were selected and streaked onto minimal glucose agar plates for preparation of antigen.
The 11 bred gilts were divided into two groups and used to determine the efficacy of the vaccine as described above. The first group consisted of five gilts. Each animal received two subcutaneous immunizations. The first was at 6 to 7 weeks prior to farrowing, and the second was given 3 weeks later. The second group consisted of six gilts which were held as unvaccinated controls. When the gilts farrowed, each newborn pig was deprived of colostrum and challenged within 6 to 12 h intragastrically with 2 x 109 E. coli E/001 cells. Each pig was observed for 7 days following the challenge. The pigs were monitored to determine the duration and severity of scours, which were scored as follows: 0, no scours; 1, mild scours with no dehydration; 2, moderate scours with dehydration; 3, severe scours with dehydration, depression, and mortality. Blood samples were collected from each gilt prior to vaccination, at the time the booster was administered, and just after farrowing. Each sample was titrated against type 1 pilus antigen by using the agglutination test (26) . Colostrum samples from three vaccinated animals and three controls were titrated against piliated and nonpiliated phenotypes.
RESULTS
As shown in Fig. 1, 6 .6 x 106 organisms were recovered from ileal segments of pigs which were challenged with E. coli A/001 following administration of normal serum. Sixfold fewer organisms (P < 0.05) (1.1 x 106 cells) were recovered from ileal segments of pigs which received type 1 pilus antiserum prior to challenge. The organisms which were recovered from the ileal segments demonstrated mannosesensitive hemagglutination of guinea pig erythrocytes. Fig7x1Q6 (Fig. 2b) .
The purified type 1 pili produced one band at a molecular weight of 18,000 in sodium dodecyl sulfate-polyacrylamide 45K gel electrophoresis preparations (Fig. 3) . The immunodiffusion assay revealed a single precipitin line between the wells containing type 1 pili and type 1 pilus antiserum. No precipitin lines formed between type 1 pili and antisera to type K88, K99, 987P, and F41 pili (Fig. 4) However, pigs in the vaccinated group developed mild scours, whereas control pigs developed severe scours (Fig.  6) . Scours lasted for a significantly shorter time (P < 0.001) in the vaccinated group (1.9 days) than in the control group (4.2 days). As shown in Fig. 6 , pigs born to the vaccinated group developed significantly less scours (P < 0.001) (scours score, 1.6) than pigs born to control groups (scours score, 2.6). Pigs born to vaccinated gilts gained significantly more weight (P < 0.01) (average, 2.4 in Table 2 , sera and colostrum samples from vaccinated gilts showed significant increases (P < 0. 
